Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Clinical Lung Cancer|February 15, 2015
Treatment Patterns and Health Resource Utilization Among Patients Diagnosed With Early Stage Resected Non-Small Cell Lung Cancer at US Community Oncology PracticesPhilip O Buck, Kimberly R Saverno, Paul J E Miller, et al.
Breast (Edinburgh, Scotland)|November 11, 2022
Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2‒Negative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and IsraelReshma Mahtani, Alexander Niyazov, Bhakti Arondekar, et al.
Cancers|November 11, 2022
<i>BRCA1/2</i> Mutation Testing in Patients with HER2-Negative Advanced Breast Cancer: Real-World Data from the United States, Europe, and IsraelReshma Mahtani, Alexander Niyazov, Bhakti Arondekar, et al.
Journal of Managed Care & Specialty Pharmacy|January 24, 2015
Economic burden associated with adverse events in patients with metastatic melanomaBhakti Arondekar, Suellen Curkendall, Matthew Monberg, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 1, 2019
Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisonsGabriel Tremblay, Tracy Westley, Joseph C Cappelleri, et al.
Diabetes Research and Clinical Practice|January 22, 2008
Psychometric evaluation of the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS)Christina Donatti, Diane Wild, Ruslan Horblyuk, et al.
The Oncologist|April 4, 2023
Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International StudyPedro C Barata, Andrea Leith, Amanda Ribbands, et al.
The Oncologist|April 4, 2023
Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International StudyPedro C Barata, Andrea Leith, Amanda Ribbands, et al.
JNCI Cancer Spectrum|February 13, 2025
Do trial benefits predict real-world gains in metastatic castration resistant prostate cancerSarah Axeen, Alice J Chen, Darius N Lakdawalla, et al.
The American Journal of Medicine|January 4, 2014
Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemiaJennifer B Christian, Bhakti Arondekar, Erin K Buysman, et al.
Pageof 5